KL-6, A MUCIN-LIKE GLYCOPROTEIN, IN BRONCHOALVEOLAR LAVAGE FLUID FROM PATIENTS WITH INTERSTITIAL LUNG-DISEASE

被引:236
作者
KOHNO, N
AWAYA, Y
OYAMA, T
YAMAKIDO, M
AKIYAMA, M
INOUE, Y
YOKOYAMA, A
HAMADA, H
FUJIOKA, S
HIWADA, K
机构
[1] HIROSHIMA UNIV,SCH MED,DEPT INTERNAL MED 2,HIROSHIMA 730,JAPAN
[2] RADIAT EFFECTS RES FDN,DEPT RADIAT BIOL,HIROSHIMA 730,JAPAN
来源
AMERICAN REVIEW OF RESPIRATORY DISEASE | 1993年 / 148卷 / 03期
关键词
D O I
10.1164/ajrccm/148.3.637
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
KL-6, a mucin-like high-molecular-weight glycoprotein, is a serum marker indicating the disease activity of pneumonitis, such as idiopathic pulmonary fibrosis (IPF), hypersensitivity pneumonitis, and sarcoidosis. Immunohistochemical studies have shown that KL-6 is strongly expressed on Type 2 pneumocytes and also exists on epithelial cells in other organs. It has not been clarified whether the increased levels of KL-6 in sera from patients with pneumonitis are derived from the lower respiratory tract. In this study, KL-6 levels were evaluated in bronchoalveolar lavage fluid (BALF) samples from 9 healthy control subjects and 32 patients with interstitial pneumonitis. An abnormally high level of KL-6 in BALF was observed in 70% (7 of 10) of patients with IPF, 64% (9 of 14) of patients with sarcoidosis, and 100% (8 of 8) of patients with hypersensitivity pneumonitis but in none of the healthy control subjects. KL-6 levels in BALF were significantly correlated with numbers of total cells (p < 0.001), lymphocytes (p < 0.001), and neutrophils (p < 0.05) and with concentrations of albumin (p < 0.001) and total protein (p < 0.001) in BALF and, further, with serum KL-6 levels (p < 0.01). These results indicate that increased levels of serum KL-6 in patients with pneumonitis reflect the production levels of KL-6 derived from damaged or regenerating Type 2 pneumocytes in the lower respiratory tract.
引用
收藏
页码:637 / 642
页数:6
相关论文
共 35 条
[1]   JAPANESE SUMMER-TYPE HYPERSENSITIVITY PNEUMONITIS - GEOGRAPHIC-DISTRIBUTION, HOME-ENVIRONMENT, AND CLINICAL CHARACTERISTICS OF 621 CASES [J].
ANDO, M ;
ARIMA, K ;
YONEDA, R ;
TAMURA, M .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (04) :765-769
[2]  
BELL DY, 1981, AM REV RESPIR DIS, V124, P72
[3]   EXTRACELLULAR-MATRIX COMPONENTS IN BRONCHOALVEOLAR LAVAGE FLUID IN SARCOIDOSIS AND THEIR RELATIONSHIP TO SIGNS OF ALVEOLITIS [J].
BLASCHKE, E ;
EKLUND, A ;
HERNBRAND, R .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 141 (04) :1020-1025
[4]   THE ROENTGENOGRAPHIC STAGING OF SARCOIDOSIS - HISTORIC AND CONTEMPORARY PERSPECTIVES [J].
DEREMEE, RA .
CHEST, 1983, 83 (01) :128-133
[5]  
FOUNIER E, 1985, CHESTS, V88, P563
[6]   ANTI-ELASTASES OF THE HUMAN ALVEOLAR STRUCTURES - IMPLICATIONS FOR THE PROTEASE-ANTIPROTEASE THEORY OF EMPHYSEMA [J].
GADEK, JE ;
FELLS, GA ;
ZIMMERMAN, RL ;
RENNARD, SI ;
CRYSTAL, RG .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (04) :889-898
[7]   MONITORING OF SERUM KL-6 ANTIGEN IN A PATIENT WITH RADIATION PNEUMONIA [J].
HAMADA, H ;
KOHNO, N ;
AKIYAMA, M ;
HIWADA, K .
CHEST, 1992, 101 (03) :858-860
[8]   A RAISED LEVEL OF SOLUBLE-CD8 IN BRONCHOALVEOLAR LAVAGE FLUID IN SUMMER-TYPE HYPERSENSITIVITY PNEUMONITIS IN JAPAN [J].
HAMAGAMI, S ;
MIYAGAWA, T ;
OCHI, T ;
TSUYUGUCHI, I ;
KISHIMOTO, S .
CHEST, 1992, 101 (04) :1044-1049
[9]   STRUCTURAL FEATURES OF INTERSTITIAL LUNG-DISEASE IN SYSTEMIC-SCLEROSIS [J].
HARRISON, NK ;
MYERS, AR ;
CORRIN, B ;
SOOSAY, G ;
DEWAR, A ;
BLACK, CM ;
DUBOIS, RM ;
TURNERWARWICK, M .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (03) :706-713
[10]   BRONCHOALVEOLAR LAVAGE FLUID CELL COUNTS IN CRYPTOGENIC FIBROSING ALVEOLITIS AND THEIR RELATION TO THERAPY [J].
HASLAM, PL ;
TURTON, CWG ;
LUKOSZEK, A ;
SALSBURY, AJ ;
DEWAR, A ;
COLLINS, JV ;
TURNERWARWICK, M .
THORAX, 1980, 35 (05) :328-339